Department of Internal Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Faculty of Science, Razi University, Kermanshah, Iran.
Carbohydr Res. 2020 Mar;489:107927. doi: 10.1016/j.carres.2020.107927. Epub 2020 Jan 24.
Diabetes mellitus is the most common metabolic disorder characterized by chronic hyperglycemia. There has been a surge of research studies aiming to use natural products in the management of diabetes. The objective of this study was to isolate and characterize the structure and anti-diabetic mechanisms of the main ingredient from Rosa canina. The oligosaccharide was isolated from Rosa canina fruits and characterized by a combination of FTIR, NMR and Mass spectrometry. Wistar rats were divided into negative control, diabetic (type 2), isolated oligosaccharide (IO)-treated diabetic and positive diabetic controls. Oral glucose tolerance, gluconeogenesis and α-glucosidase inhibitory tests as well as immunohistochemistry and quantitative real time-PCR were performed to elucidate the molecular anti-diabetic mechanisms of IO. Structural analyses confirmed the oligosaccharide structure of isolated fraction. Gluconeogenesis and α-glucosidase activity were inhibited by IO in diabetic rats. The oral glucose tolerance test was improved significantly in the group treated with the IO (P < 0.05). Pancreatic β-cells and tissue pathological examination showed a significant improvement after the treatment period. In addition, the expression of Ngn3, Nkx6.1 and insulin increased in oligosaccharide-treated compared to untreated diabetic rats. Owing to the verified anti-diabetic effects and regenerative potential, isolated oligosaccharide could be considered as the promising drug in the management of diabetes.
糖尿病是最常见的代谢紊乱疾病,其特征为慢性高血糖。目前已经有大量研究旨在利用天然产物来治疗糖尿病。本研究的目的是从玫瑰果中分离并鉴定其主要成分的结构和抗糖尿病机制。从玫瑰果中分离出寡糖,并通过傅里叶变换红外光谱(FTIR)、核磁共振(NMR)和质谱联用(Mass spectrometry)对其进行了表征。Wistar 大鼠被分为阴性对照组、糖尿病(2 型)组、分离的寡糖(IO)治疗糖尿病组和阳性糖尿病对照组。进行口服葡萄糖耐量、糖异生和α-葡萄糖苷酶抑制试验以及免疫组织化学和实时定量 PCR,以阐明 IO 的分子抗糖尿病机制。结构分析证实了分离部分的寡糖结构。IO 抑制了糖尿病大鼠的糖异生和α-葡萄糖苷酶活性。IO 治疗组的口服葡萄糖耐量试验明显改善(P<0.05)。胰腺β细胞和组织病理学检查显示,治疗后有明显改善。此外,与未治疗的糖尿病大鼠相比,寡糖治疗组的 Ngn3、Nkx6.1 和胰岛素表达增加。由于已证实的抗糖尿病作用和再生潜力,分离的寡糖可被视为治疗糖尿病的有前途的药物。